As of 2025-03-20, the EV/EBITDA ratio of Exagen Inc (XGN) is -5.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 62.42 mil USD. XGN's TTM EBITDA according to its financial statements is -11.91 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.6x - 9.4x | 8.2x |
| Forward P/E multiples | 7.0x - 7.8x | 7.4x |
| Fair Price | (5.04) - (5.17) | (5.20) |
| Upside | -239.2% - -242.9% | -243.7% |
| Date | EV/EBITDA |
| 2025-03-14 | -5.15 |
| 2025-03-13 | -4.84 |
| 2025-03-12 | -4.81 |
| 2025-03-11 | -4.87 |
| 2025-03-10 | -4.10 |
| 2025-03-07 | -4.66 |
| 2025-03-06 | -4.51 |
| 2025-03-05 | -4.60 |
| 2025-03-04 | -4.34 |
| 2025-03-03 | -4.41 |
| 2025-02-28 | -5.00 |
| 2025-02-27 | -5.14 |
| 2025-02-26 | -5.09 |
| 2025-02-25 | -4.99 |
| 2025-02-24 | -5.21 |
| 2025-02-21 | -5.18 |
| 2025-02-20 | -5.48 |
| 2025-02-19 | -5.57 |
| 2025-02-18 | -5.46 |
| 2025-02-14 | -6.14 |
| 2025-02-13 | -6.20 |
| 2025-02-12 | -6.28 |
| 2025-02-11 | -6.97 |
| 2025-02-10 | -6.99 |
| 2025-02-07 | -7.52 |
| 2025-02-06 | -7.68 |
| 2025-02-05 | -7.77 |
| 2025-02-04 | -7.31 |
| 2025-02-03 | -5.63 |
| 2025-01-31 | -5.80 |
| 2025-01-30 | -5.95 |
| 2025-01-29 | -5.91 |
| 2025-01-28 | -5.89 |
| 2025-01-27 | -5.86 |
| 2025-01-24 | -5.80 |
| 2025-01-23 | -5.79 |
| 2025-01-22 | -5.86 |
| 2025-01-21 | -5.82 |
| 2025-01-17 | -5.79 |
| 2025-01-16 | -4.41 |
| 2025-01-15 | -4.50 |
| 2025-01-14 | -4.32 |
| 2025-01-13 | -4.50 |
| 2025-01-10 | -4.57 |
| 2025-01-08 | -4.75 |
| 2025-01-07 | -4.72 |
| 2025-01-06 | -4.90 |
| 2025-01-03 | -5.18 |
| 2025-01-02 | -4.46 |
| 2024-12-31 | -5.95 |